Chiusura precedente | 70,00 |
Aperto | 70,00 |
Denaro | 69,50 x N/D |
Lettera | 71,50 x N/D |
Min-Max giorno | 70,00 - 70,00 |
Intervallo di 52 settimane | 43,80 - 70,00 |
Volume | |
Media Volume | 11 |
Capitalizzazione | N/D |
Beta (5 anni mensile) | N/D |
Rapporto PE (ttm) | N/D |
EPS (ttm) | N/D |
Prossima data utili | 30 lug 2024 - 05 ago 2024 |
Rendimento e dividendo (futuro) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | N/D |
BURLINGTON, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2023 results, announced a $0.14/share quarterly dividend and provided guidance. Q2 2023 Financial Results Sales $50.1mm, +19% (+16% organic) vs. Q2 2022Op. income $9.5mm, +63% (+8% adjusted)Op. margin 19%Net income $8.1mm, +130% (+27% adjusted)Earnings per diluted share $0.36, +127% (+25% adjusted)Cash up $9.2mm to $90.2mm Bovine patches (+16%), va
BURLINGTON, Mass., July 31, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences in August. JJ Pellegrino, Chief Financial Officer, will participate in the 8th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Monday, August 14, 2023. David Roberts, President, will present at the UBS MedTech, Tools and Genomics Summit at the Waldorf Astoria in Dana Point, CA. The company’s presentation is schedul
BURLINGTON, Mass., July 17, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2023 financial results on Tuesday, August 1, 2023, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to